ID: ALA5196128

Max Phase: Preclinical

Molecular Formula: C17H21ClFN

Molecular Weight: 257.35

Representations

Canonical SMILES:  CC12CC3c4c(F)cccc4C4CC(N)(C1)CC43C2.Cl

Standard InChI:  InChI=1S/C17H20FN.ClH/c1-15-5-12-14-10(3-2-4-13(14)18)11-6-16(19,7-15)9-17(11,12)8-15;/h2-4,11-12H,5-9,19H2,1H3;1H

Standard InChI Key:  BKLHITXSIJSTJJ-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 257.35

Molecular Weight (Monoisotopic): 257.1580

AlogP: 3.69

#Rotatable Bonds: 0

Polar Surface Area: 26.02

Molecular Species: BASE

HBA: 1

HBD: 1

#RO5 Violations: 0

HBA (Lipinski): 1

HBD (Lipinski): 2

#RO5 Violations (Lipinski): 0

CX Acidic pKa:

CX Basic pKa: 10.53

CX LogP: 2.79

CX LogD: 0.01

Aromatic Rings: 1

Heavy Atoms: 19

QED Weighted: 0.75

Np Likeness Score: 0.53

References

1. Turcu AL, Companys-Alemany J, Phillips MB, Patel DS, Griñán-Ferré C, Loza MI, Brea JM, Pérez B, Soto D, Sureda FX, Kurnikova MG, Johnson JW, Pallàs M, Vázquez S..  (2022)  Design, synthesis, and in vitro and in vivo characterization of new memantine analogs for Alzheimer's disease.,  236  [PMID:35453065] [10.1016/j.ejmech.2022.114354]

Source

Source(1):

• Scientific Literature